extra semaglutide in vial Medications Safety Information Tirzepatide & Semaglutide Weight Loss

Among the tirzepatide groups, 32% (5 mg), 51% (10 mg), and 60% (15 mg) of participants hit this triple target

Reddy IA, Pino JA, Weikop P, Osses N, Srensen G, Bering T, et al

Less than one per cent of people with obesity are taking these drugs, so I think a lot of that is hype, too

Patients should contact their GP or diabetes specialist nurse if dizziness is: Severe or persistent , significantly impacting daily activities or quality of life Associated with recurrent hypoglycaemia , particularly readings below 4.0 mmol/L or readings below 3.0 mmol/L (level 2 hypoglycaemia) or episodes requiring assistance from others Accompanied by other concerning symptoms such as chest pain, palpitations, severe headache, visual disturbances, slurred speech, or weakness Resulting in falls or near-falls , which pose injury risk, especially in older adults or those with reduced mobility Immediate medical attention (via 999 or attendance at A&E) is required if dizziness occurs alongside: Signs of severe hypoglycaemia with confusion, loss of consciousness, or seizure activity Symptoms suggesting cardiovascular events (severe chest pain, breathlessness, or syncope) Neurological symptoms that might indicate stroke (facial drooping, arm weakness, speech difficulties - remember the FAST acronym) Severe dehydration with inability to retain fluids, reduced urine output, or altered consciousness For urgent but non-life-threatening concerns when unsure what to do, NHS 111 can provide appropriate clinical advice

In the SUSTAIN trials, semaglutide cut HbA1c by 1.5-1.9% at the 0.5-1.0 mg doses

Available at: [accessed March 2026]. Wilding JPH, Batterham RL, Calanna S, et al